Citation Impact
Citing Papers
Alpelisib for PIK3CA -Mutated, Hormone Receptor–Positive Advanced Breast Cancer
2019 Standout
Estrogen Receptor Status by Immunohistochemistry Is Superior to the Ligand-Binding Assay for Predicting Response to Adjuvant Endocrine Therapy in Breast Cancer
1999 Standout
Hypoxia-inducible factors and RAB22A mediate formation of microvesicles that stimulate breast cancer invasion and metastasis
2014 StandoutNobel
PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro
2009
Overexpression of hypoxia-inducible factor 1alpha is associated with an unfavorable prognosis in lymph node-positive breast cancer.
2002
Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials
2011 Standout
Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials
2011 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Gene expression profiling predicts clinical outcome of breast cancer
2002 StandoutNature
A comparative analysis of radiotherapy use and patient outcome in males and females with breast cancer
2005
Breast cancer
2016 Standout
Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer
2013 Standout
Cancer nanomedicine: progress, challenges and opportunities
2016 Standout
Targeting HIF-1 for cancer therapy
2003 StandoutNobel
Breast-Conserving Surgery With or Without Radiotherapy in Older Breast Patients With Early Stage Breast Cancer: A Systematic Review and Meta-analysis
2013
Contribution of platelets to tumour metastasis
2011 Standout
Carcinoma of the breast in males
1998
Human ADAR1 Prevents Endogenous RNA from Triggering Translational Shutdown
2018 StandoutNobel
EMT and Dissemination Precede Pancreatic Tumor Formation
2012 Standout
Primary Care for Survivors of Breast Cancer
2000
Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer
2005 Standout
Understanding the tumor immune microenvironment (TIME) for effective therapy
2018 Standout
Preoperative thrombocytosis predicts poor survival in patients with glioblastoma
2007
Balancing Acts
2004 Standout
Clinical relevance of biologic factors in male breast cancer
2001
Antitumour actions of interferons: implications for cancer therapy
2016
Relationship Between Long Durations and Different Regimens of Hormone Therapy and Risk of Breast Cancer
2003
Male breast carcinoma
1999
The EndoPredict score provides prognostic information on late distant metastases in ER+/HER2− breast cancer patients
2013
Hypoxia-inducible factor–dependent breast cancer–mesenchymal stem cell bidirectional signaling promotes metastasis
2012 StandoutNobel
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
Karnofsky Memorial Lecture. Natural history of small breast cancers.
1994
Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years
2016
Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancer
2004
2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours
2010 Standout
Cyclin D as a therapeutic target in cancer
2011
Male breast cancer
2006 Standout
Common genetic variants at the 11q13.3 renal cancer susceptibility locus influence binding of HIF to an enhancer of cyclin D1 expression
2012 StandoutNobel
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
Twenty-Five-Year Follow-up of a Randomized Trial Comparing Radical Mastectomy, Total Mastectomy, and Total Mastectomy Followed by Irradiation
2002 Standout
Emerging Biological Principles of Metastasis
2017 Standout
Male breast cancer. Evolution of treatment and prognostic factors. Analysis of 489 cases
2009
Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication
2006
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
2004 Standout
A prospective study of adjuvant CMF in males with node positive breast cancer: 20-year follow-up
2006
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2019 Standout
Late Recurrences in Early Breast Cancer: For Whom and How Long Is Endocrine Therapy Beneficial?
2014
Glypican-1 identifies cancer exosomes and detects early pancreatic cancer
2015 StandoutNature
A Randomised Controlled Trial to Evaluate both the Role and the Optimal Fractionation of Radiotherapy in the Conservative Management of Early Breast Cancer
2012
Hypoxia inducible factor-1α correlates with VEGF-C expression and lymphangiogenesis in breast cancer
2006
Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial
2010
Palbociclib and Letrozole in Advanced Breast Cancer
2016 Standout
Immunohistochemistry compared to cytosol assays for determination of estrogen receptor and prediction of the long-term effect of adjuvant tamoxifen
2010
The tumour-induced systemic environment as a critical regulator of cancer progression and metastasis
2014
Body weight and incidence of breast cancer defined by estrogen and progesterone receptor status—A meta‐analysis
2008
Anastrozole versus tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial
2015
Metastatic colonization by circulating tumour cells
2016 StandoutNature
Ductal carcinoma in situ (DCIS) in the male breast
1998
Extended adjuvant endocrine therapy in hormone-receptor positive early breast cancer: Current and future evidence
2015
Radiation therapy and tamoxifen after breast-conserving surgery: Updated results of a 2×2 randomised clinical trial in patients with low risk of recurrence
2009
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
Platelet–cancer interactions: mechanisms and pharmacology of tumour cell‐induced platelet aggregation
2004
Male breast cancer
2009
Axillary lymph nodes and breast cancer. A review
1995
Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics
2009 StandoutNobel
Preservation of Fertility in Patients with Cancer
2009 Standout
Anemia of Chronic Disease
2005 Standout
Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial
2015
Lymphatic Mapping and Sentinel Node Biopsy in the Patient With Breast Cancer
1996 Standout
Extracellular vesicles: Exosomes, microvesicles, and friends
2013 Standout
Meeting Highlights: International Consensus Panel on the Treatment of Primary Breast Cancer
2001
Breast cancer and hormone-replacement therapy in the Million Women Study
2003 Standout
Progress and controversies: Radiation therapy for invasive breast cancer
2013
An analysis of male and female breast cancer treatment and survival among demographically identical pairs of patients
1999
American Society of Clinical Oncology Clinical Practice Guideline: Update on Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer
2010
Platelets at the interface of thrombosis, inflammation, and cancer
2015
Radiotherapy After Segmental Resection of Breast Cancer With Favorable Prognostic Features: 12-Year Follow-Up Results of a Randomized Trial
2008
Breast Cancer Treatment
2019 Standout
Lumpectomy Plus Tamoxifen With or Without Irradiation in Women Age 70 Years or Older With Early Breast Cancer: Long-Term Follow-Up of CALGB 9343
2013
2000 Update of Recommendations for the Use of Tumor Markers in Breast and Colorectal Cancer: Clinical Practice Guidelines of the American Society of Clinical Oncology*
2001
National Institutes of Health Consensus Development Conference Statement: Adjuvant Therapy for Breast Cancer, November 1-3, 2000
2001
Goserelin Versus Cyclophosphamide, Methotrexate, and Fluorouracil as Adjuvant Therapy in Premenopausal Patients With Node-Positive Breast Cancer: The Zoladex Early Breast Cancer Research Association Study
2002
Endocrine Therapy for Hormone Receptor–Positive Metastatic Breast Cancer: American Society of Clinical Oncology Guideline
2016
Strategies in treating male breast cancer
2007
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Hypoxia-inducible factor 1-dependent expression of platelet-derived growth factor B promotes lymphatic metastasis of hypoxic breast cancer cells
2012 StandoutNobel
T cell exclusion, immune privilege, and the tumor microenvironment
2015 StandoutScience
Multidisciplinary Meeting on Male Breast Cancer: Summary and Research Recommendations
2010 Standout
Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials
2014 Standout
Hypoxia-inducible factor-dependent signaling between triple-negative breast cancer cells and mesenchymal stem cells promotes macrophage recruitment
2014 StandoutNobel
Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy
2016 Standout
Post-mastectomy radiation in male breast cancer
2002
Regulation of ferritin genes and protein
2002
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials
2005 Standout
Works of M. Stierer being referenced
Immunohistochemical and Biochemical Measurement of Estrogen and Progesterone Receptors in Primary Breast Cancer Correlation of Histopathology and Prognostic Factors
1993
Significant Increase in Breast Conservation in 16 Years of Trials Conducted by the Austrian Breast & Colorectal Cancer Study Group
2003
Dose intensification of epidoxorubicin and cyclophosphamide in metastatic breast cancer: a randomised study with two schedules of granulocyte-macrophage colony stimulating factor
1998
A prospective analysis of immunohistochemically determined hormone receptors and nuclear features as predictors of early recurrence in primary breast cancer
1995
Randomized Trial of Low-Dose Chemotherapy Added to Tamoxifen in Patients With Receptor-Positive and Lymph Node–Positive Breast Cancer
1999
Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial
2015
Lumpectomy Plus Tamoxifen or Anastrozole With or Without Whole Breast Irradiation in Women With Favorable Early Breast Cancer
2007
Expression of p43 in breast cancer tissue, correlation with prognostic parameters
1992
Influence of early diagnosis on prognosis of recurrent breast cancer
1989
Effect of Interferon Alpha-2a on Hormone Receptor Status in Patients with Advanced Breast Cancer
1999
Comparison of immunohistochemical and biochemical measurement of steroid receptors in primary breast cancer: Evaluation of discordant findings
1998
The predictive impact of body mass index on the efficacy of extended adjuvant endocrine treatment with anastrozole in postmenopausal patients with breast cancer: an analysis of the randomised ABCSG-6a trial
2013
Extended Adjuvant Therapy With Anastrozole Among Postmenopausal Breast Cancer Patients: Results From the Randomized Austrian Breast and Colorectal Cancer Study Group Trial 6a
2007
Cyclin D1 Expression in Breast Cancer Patients Receiving Adjuvant Tamoxifen-Based Therapy
2008
Tamoxifen and anastrozole as a sequencing strategy in postmenopausal women with hormone-responsive early breast cancer: updated data from the Austrian breast and colorectal cancer study group trial 8.
2009
Impact of pretreatment thrombocytosis on survival in primary breast cancer
2003
Male breast cancer: Austrian experience
1995
Extended adjuvant treatment with anastrozole: Results from the Austrian Breast and Colorectal Cancer Study Group Trial 6a (ABCSG-6a)
2005
Long term analysis of factors influencing the outcome in carcinoma of the breast smaller than one centimeter.
1992
Randomized Trial of Tamoxifen Versus Tamoxifen Plus Aminoglutethimide as Adjuvant Treatment in Postmenopausal Breast Cancer Patients With Hormone Receptor-Positive Disease: Austrian Breast and Colorectal Cancer Study Group Trial 6
2003
Comparison of adjuvant therapy with tamoxifen and goserelin vs. CMF in premenopausal stage I and II hormone-responsive breast cancer patients: four-year results of Austrian Breast Cancer Study Group (ABCSG) trial 5
1999